Division of Colon and Rectal Research

The Division of Colon and Rectal Surgery at Mount Sinai has a long history of combining cutting-edge research with world-class clinical practice. As one of the nation's busiest colon and rectal centers, Mount Sinai has long been at the forefront of treating and studying inflammatory bowel disease, including Crohn's disease and Ulcerative Colitis.

We have participated in large multi-center clinical trials and are also actively engaged in the following students, which are driven by data from our own patient populations:

  • Through a multi-center prospective trial, we are examining the use of a bioprosthetic plug for the repair of perianal fistulae in patients with Crohn's disease, and surgeons within the Division have been studying the efficacy of various surgical techniques for repair of Crohn's fistulae.

  • We are looking at the cost effectiveness of ileostomy in the surgery for Ulcerative Colitis and the appropriate use of minimally invasive techniques, such as "single incision laparoscopic surgery" (SILS) for colon resection.

  • Surgeons are examining the utility of "transanal endoscopic microsurgery" (TEMS) for local resection of various rectal lesions to thereby avoid subjecting patients to extremely invasive procedures.

  • We recently participated in a study of a new colostomy continence device and, in a collaborative effort with Memorial Sloan Kettering Cancer Center, we are studying the sexual health of patients following surgery for rectal cancer. By collaborating with faculty in other academic departments, we are seeking to understand and characterize changes in liver histology seen in patients with both Ulcerative Colitis and Crohn's Disease.

Faculty members in the Division of Colon and Rectal Surgery continually integrate clinical research into their daily surgical practice in order to ensure that all patients get the best possible care for a wide variety of colon, rectal and anal problems.

Currently accepting patients for the following study:
Multicenter Phase II Study of Transanal Total Mesorectal Excision (taTME) With Laparoscopic Assistance for Rectal Cancer